Figma, Inc. (NYSE:FIG – Get Free Report) CAO Tyler Herb sold 2,840 shares of the company’s stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $37.15, for a total value of $105,506.00. Following the completion of the sale, the chief accounting officer owned 198,158 shares in the company, valued at approximately $7,361,569.70. This represents a 1.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Tyler Herb also recently made the following trade(s):
- On Friday, January 2nd, Tyler Herb sold 2,408 shares of Figma stock. The stock was sold at an average price of $37.21, for a total value of $89,601.68.
- On Wednesday, December 3rd, Tyler Herb sold 2,310 shares of Figma stock. The shares were sold at an average price of $36.60, for a total value of $84,546.00.
- On Monday, December 1st, Tyler Herb sold 3,073 shares of Figma stock. The shares were sold at an average price of $35.45, for a total value of $108,937.85.
- On Monday, November 17th, Tyler Herb sold 757 shares of Figma stock. The stock was sold at an average price of $38.21, for a total value of $28,924.97.
- On Monday, November 10th, Tyler Herb sold 43,357 shares of Figma stock. The stock was sold at an average price of $43.93, for a total transaction of $1,904,673.01.
- On Monday, November 3rd, Tyler Herb sold 3,133 shares of Figma stock. The shares were sold at an average price of $48.17, for a total transaction of $150,916.61.
Figma Price Performance
NYSE:FIG opened at $37.34 on Thursday. The stock has a market cap of $15.53 billion and a P/E ratio of -13.93. The company’s 50-day simple moving average is $39.05. Figma, Inc. has a twelve month low of $32.83 and a twelve month high of $142.92.
Hedge Funds Weigh In On Figma
Large investors have recently added to or reduced their stakes in the business. Voya Investment Management LLC purchased a new stake in Figma in the 3rd quarter valued at about $3,412,000. VERITY Wealth Advisors purchased a new position in shares of Figma during the 3rd quarter worth about $519,000. Tripletail Wealth Management LLC acquired a new stake in shares of Figma in the third quarter worth approximately $53,000. Renaissance Capital LLC purchased a new stake in Figma in the third quarter valued at approximately $2,439,000. Finally, SOA Wealth Advisors LLC. purchased a new stake in Figma in the third quarter valued at approximately $39,000.
More Figma News
Here are the key news stories impacting Figma this week:
- Positive Sentiment: Strong fundamentals: Figma reported better‑than‑expected quarterly results (Nov. 5) — $0.10 EPS vs. a large consensus miss, and revenue of $274.2M, up ~38% year‑over‑year — evidence of continued user and revenue growth. Figma stock summary and earnings
- Positive Sentiment: Product momentum / ecosystem activity: new how‑to and demo content (Design→production code with Figma MCP, tutorials) highlights continued product adoption and developer/designer engagement — supportive long‑term demand even if not market moving short term. Design to production code with Figma MCP
- Neutral Sentiment: Analyst stance: Stifel Nicolaus initiated coverage with a Hold, reflecting balanced view on growth vs. AI / valuation uncertainty; the consensus remains a Hold with an average target around $59, signaling limited near‑term upside in analysts’ view. Stifel Hold initiation (TipRanks)
- Negative Sentiment: Price target cut: RBC Capital cut its target to $38 (from $65), a notable downward revision that likely reduced investor expectations for near‑term upside. RBC price target lowered to $38
- Negative Sentiment: Heavy insider selling: multiple senior executives disclosed open‑market sales in early January (CTO sold ~181k shares, CFO/CRO/GC/CAO also sold smaller blocks). Large insider sales can weigh on sentiment by signaling diversification or liquidity needs. SEC filing for a large CTO sale: CTO Form 4 filing and CAO sale summary: InsiderTrades CAO sale alert
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on FIG shares. Stifel Nicolaus set a $40.00 price target on Figma in a research report on Wednesday. JPMorgan Chase & Co. decreased their price objective on Figma from $65.00 to $60.00 and set a “neutral” rating on the stock in a research note on Thursday, November 6th. Piper Sandler dropped their price objective on Figma from $85.00 to $70.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. Wells Fargo & Company cut their target price on shares of Figma from $70.00 to $52.00 and set an “equal weight” rating for the company in a research note on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Figma in a research note on Monday, December 29th. Three analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $56.63.
Check Out Our Latest Stock Report on Figma
Figma Company Profile
Figma is a San Francisco–based software company that offers a web-based platform for interface design, prototyping and collaboration. Its flagship product, Figma, enables teams to create and refine user interfaces, vector graphics and design systems directly in a browser, eliminating the need for local installations. The platform’s real-time collaboration features allow multiple stakeholders—designers, developers and product managers—to edit and comment simultaneously, streamlining workflows and reducing version control issues.
In addition to its core design tool, Figma provides FigJam, a digital whiteboarding solution that facilitates brainstorming sessions, wireframing and diagramming.
See Also
- Five stocks we like better than Figma
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Figma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Figma and related companies with MarketBeat.com's FREE daily email newsletter.
